Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study

By Hadjiyannakos Dimitrios   Filiopoulos Vassilis   Trompouki Sofia   Sonikian Makroui   Karatzas Ioannis   Panagiotopoulos Konstantinos   Vlassopoulos Dimosthenis  

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 164-168

Oxford University Press

Access to resources Recommend Favorite

L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension

By Ogura Chika   Ono Koh   Miyamoto Shoichi   Ikai Akiko   Mitani Satoko   Sugimoto Naozo   Tanaka Shiro   Fujita Masatoshi  

Blood Pressure, Vol. 21, Iss. 6, 2012-12 ,pp. : 367-371

Informa Healthcare

Access to resources Recommend Favorite

Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update

By  

Current Cardiology Reviews, Vol. 9, Iss. 4, 2013-11 ,pp. : 331-339

Bentham Science Publishers

Access to resources Recommend Favorite

Functional and Molecular Characterization of a T-type Ca²⁺ Channel During Fetal and Postnatal Rat Heart Development

By Ferron L.   Capuano V.   Deroubaix E.   Coulombe A.   Renaud J-F.  

Journal of Molecular and Cellular Cardiology, Vol. 34, Iss. 5, 2002-05 ,pp. : 533-546

Academic Press

Access to resources Recommend Favorite

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients

By de Oliveira Rodrigo Bueno   Liabeuf Sophie   Okazaki Hirokazu   Lenglet Aurelie   Desjardins Lucie   Lemke Horst-Dieter   Vanholder Raymond   Choukroun Gabriel   Massy Ziad A.  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 63-70

Oxford University Press

Access to resources Recommend Favorite